izpis_h1_title_alt

Oxidation of drugs during drug product development : problems and solutions
ID Gabrič, Alen (Author), ID Hodnik, Žiga (Author), ID Pajk, Stane (Author)

.pdfPDF - Presentation file, Download (6,42 MB)
MD5: D229AF12DCF58E3F810422567FDE54AD
URLURL - Source URL, Visit https://www.mdpi.com/1999-4923/14/2/325 This link opens in a new window

Abstract
Oxidation is the second most common degradation pathway for pharmaceuticals, after hydrolysis. However, in contrast to hydrolysis, oxidation is mechanistically more complex and produces a wider range of degradation products; oxidation is thus harder to control. The propensity of a drug towards oxidation is established during forced degradation studies. However, a more realistic insight into degradation in the solid state can be achieved with accelerated studies of mixtures of drugs and excipients, as the excipients are the most common sources of impurities that have the potential to initiate oxidation of a solid drug product. Based on the results of these studies, critical parameters can be identified and appropriate measures can be taken to avoid the problems that oxidation poses to the quality of a drug product. This article reviews the most common types of oxidation mechanisms, possible sources of reactive oxygen species, and how to minimize the oxidation of a solid drug product based on a well-planned accelerated study.

Language:English
Keywords:oxidation, peroxides, impurities, new oxidative stressors, oxidative stress testing
Work type:Article
Typology:1.02 - Review Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2022
Number of pages:19 str.
Numbering:Vol. 14, iss. 2, art. 325
PID:20.500.12556/RUL-136994 This link opens in a new window
UDC:542.943:615
ISSN on article:1999-4923
DOI:10.3390/pharmaceutics14020325 This link opens in a new window
COBISS.SI-ID:100590851 This link opens in a new window
Publication date in RUL:27.05.2022
Views:988
Downloads:118
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Pharmaceutics
Shortened title:Pharmaceutics
Publisher:MDPI
ISSN:1999-4923
COBISS.SI-ID:517949977 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:01.02.2022

Secondary language

Language:Slovenian
Keywords:nečistoče, novi oksidativni stresorji, testiranje oksidativnega stresa, peroksidi, zdravila, oksidacija, oksidativni stres

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0208
Name:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back